Delivery Order SPE2DB22D2009-SPE2DB25FL9UY

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,746.61, is for the delivery of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product, with a ceiling value of $1,676.34 and a completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,200.12, is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S". The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $3,327.51 firm fixed price delivery order (SPE2DB24FJRK7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of 4565461978 MUCUS RELIEF ER 600 MG TABLET 100S. The contract has an ultimate completion date of August 16, 2024. This appears to be a continuation of Amerisourcebergen's broader supply relationship with DLA, as the company holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for...
This federal contract award, valued at $2,124.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, to provide MUCUS RLF DM ER 600-30 MG TAB 40S medical products. The contract has an ultimate completion date of March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,265.80 firm fixed-price delivery order is for the supply of 500 tablets of "MUCUS RELIEF ER 600 MG TABLET" and has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.69 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets, which will be delivered by February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, that serves as a primary vehicle...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The $1,404.38 Firm Fixed Price delivery order is for Mucinex DM ER 600-30 mg tablets. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,962.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,738.15 firm fixed-price delivery order is for the provision of MUCINEX D ER 600-60 MG TABLET 18S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9UY
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,231.38 firm fixed-price delivery order is for the supply of MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/22/25, 9:49 AM